RecruitingNCT03291652

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential


Sponsor

Chinese University of Hong Kong

Enrollment

140 participants

Start Date

Feb 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).


Eligibility

Min Age: 30 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study uses advanced brain imaging to examine what makes certain plaques (atherosclerosis) inside brain arteries more likely to cause strokes. By comparing patients with and without stroke symptoms, researchers aim to identify imaging features that predict stroke risk. You may be eligible if: - You are between 30 and 85 years old - You have a significant narrowing (60% or more) in a brain artery - For the symptomatic group: you have had a recent stroke and detectable microemboli (tiny clots) on ultrasound - For the asymptomatic group: you have a narrowed brain artery but no recent stroke or clots detected - You have no contraindications to the imaging tests You may NOT be eligible if: - Your stroke was caused by something other than artery-to-artery clotting (e.g., a heart clot or Moyamoya disease) - You have a bleeding disorder or very low platelet count - You have a medical condition that would prevent you from completing the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDSA/3DRA

DSA/3DRA


Locations(1)

Chinese University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03291652


Related Trials